| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP0888545B1 Super-paramagnetic particles with increased r 1 relaxivity, processes for producing said particles and use thereof |
| 01/23/2002 | CN1078201C Prep of contrast medium 'Dianhaichun' |
| 01/22/2002 | US6340455 Performing screening test with a first reagent comprising a surface structure common to anaerobic gram negative pathogens to elicit a reaction; evaluating the reaction, lack of reaction or minor reaction |
| 01/22/2002 | CA2220349C Coatings for production of hyperpolarized noble gases |
| 01/22/2002 | CA2107556C Increasing blood-brain barrier permeability with permeabilizer peptides |
| 01/17/2002 | WO2002004917A2 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004029A1 Olfactory neuron cultures and method of making and using the same |
| 01/17/2002 | WO2002004023A2 Photoactivated drug therapy |
| 01/17/2002 | WO2001082974A3 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 01/17/2002 | WO2001054672A3 Closure of bacterial ghosts |
| 01/17/2002 | WO2001020019A3 Implantable glucose sensor |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | WO1999051284A3 Non-covalent bioconjugates useful for diagnosis and therapy |
| 01/17/2002 | US20020007221 Methods for soft tissue augmentation |
| 01/17/2002 | US20020007141 Method of removing thrombosis in fistulae |
| 01/17/2002 | US20020006382 Diagnostic procedures using direct injection of gaseous hyperpolarized 129Xe and associated systems and products |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | CA2415084A1 Olfactory neuron cultures and method of making and using the same |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171109A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 01/16/2002 | EP0915738B1 Process and device for separating magnetic materials from pharmaceutical compositions, their starting or intermediate products and agents produced by means of this device |
| 01/16/2002 | CN1331797A High energy phototherapeutic agents |
| 01/16/2002 | CN1077801C Carcinoembryonic antigen gene engineering antibody CL-3-scFv |
| 01/15/2002 | US6339716 Method for determining viability of a myocardial segment |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6338836 Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging |
| 01/10/2002 | WO2002003048A1 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002149A1 Rhodamine diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2001070291A3 Injectable microspheres for dermal augmentation and tissue bulking |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037882A3 Use of fenoldepam for protecting against radio-contrast medium-induced renal dysfunction |
| 01/10/2002 | WO2001028594A3 Tumor detection by imaging and therapy of tumors |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001002050A3 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
| 01/10/2002 | US20020004942 Transgenic plant that expresses luciferase; for use in the development of toys, foods, textiles and beverages that glow |
| 01/10/2002 | US20020004215 Adjusting preferental particles to generate signal; mix ligand and marker, enzyme, incubate, allow binding, detect signal |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2383697A1 Rhodamine diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/10/2002 | CA2383194A1 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/09/2002 | EP1170275A2 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 01/09/2002 | EP1170021A2 Conjugates of peptides and lanthanid-chelates for fluorescencediagnostic |
| 01/09/2002 | EP1169066A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 01/09/2002 | EP1169065A1 Formulations for detecting asthma |
| 01/09/2002 | EP1169064A2 Method of detecting endometriosis |
| 01/09/2002 | EP1169062A2 Heat stable coated colloidal iron oxides |
| 01/09/2002 | EP0959907A4 The butyrophilin gene promoter and uses thereof |
| 01/09/2002 | CN1330679A Plastic moulding materials which can be detected by x-ray contrast |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/08/2002 | US6337422 Yellow polymorph of 5-amino-2,4,6-triiodo-n,n′-bis(2-3-dihydroxypropy)-isophthalamide |
| 01/08/2002 | US6337357 Microbiocides, solvents, carries and dentistry |
| 01/08/2002 | US6337064 Used as contrast agent in magnetic resonance imaging, medical diagnosis |
| 01/03/2002 | WO2002000662A1 Improvements in and relating to chromophores |
| 01/03/2002 | WO2002000603A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 01/03/2002 | WO2002000265A1 Intramolecularly-quenched near infrared fluorescent probes |
| 01/03/2002 | WO2001028587A3 Magnetic targeted carrier |
| 01/03/2002 | WO2001021218A3 Method for determining viability of a myocardial segment |
| 01/03/2002 | US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 01/03/2002 | US20020001566 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/03/2002 | CA2414089A1 Improvements in and relating to chromophores |
| 01/03/2002 | CA2412568A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167383A1 Novel conjugates of opioids and endogenous carriers |
| 01/02/2002 | EP1165147A1 Assessment of gastric emptying disorders |
| 01/02/2002 | EP1165087A1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 01/02/2002 | EP1164838A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 01/02/2002 | EP0983273B1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 01/02/2002 | CN2468490Y Installation for prodn. of fluorine-18 making drug |
| 01/02/2002 | CN1329504A F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 01/01/2002 | US6335465 Sterilized 5-aminolevulinic acid |
| 01/01/2002 | US6335384 Introducing, via catheter, at vascular site to be embolized non-particulate agent; delivering, via catheter, composition comprising biocompatible polymer, dimethyl sulfoxide and water insoluble contrast agent, to precipitate polymer in situ |
| 01/01/2002 | US6335028 Implantable particles for urinary incontinence |
| 01/01/2002 | CA2041260C Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
| 12/29/2001 | CA2351902A1 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 12/27/2001 | WO2001098468A2 Proteases |
| 12/27/2001 | WO2001098354A2 Human receptors |
| 12/27/2001 | WO2001097794A2 Inhibitors of matriptase for the treatment of cancer |
| 12/27/2001 | WO2001097678A2 Imaging and targeting tumors using sickle cells |
| 12/27/2001 | WO2001055656A3 Hyperpolarization of a gas |
| 12/27/2001 | WO2001047564A3 Labelled ascorbic acid derivatives |
| 12/27/2001 | WO2001041816A3 Microparticles based on aspartic acid and use thereof as mri contrast agents |
| 12/27/2001 | WO2001000014A3 Test animal for atherosclerosis model and methods for testing and screening |
| 12/27/2001 | US20010056301 Hydrogel biomedical articles |
| 12/27/2001 | US20010055567 Uses water-soluble dyes and their biomolecule adducts, each having specific photophysical and pharmaco-chemical properties, as contrast media for fluorescence and transillumination diagnostics |